Menu

Fabien MORIN

Rueil-Malmaison

En résumé

I have 6 years experience in marketing primary care and specialty care brands across the industry's largest therapeutic areas, dealing with diverse life cycles and recently embracing with passion a new journey in sales management. I now support the growth of a talented team of 9 experienced sales representatives in the Greater Toronto Area (Toronto West, Mississauga, Oakville, Kitchener Waterloo, Brampton, Rexdale)

I get a unique educational background focused on veterinarian clinical practice, health businesses, and general management.

Passionate, eager to learn, and with strong communication skills, I relentlessly try to enhance my strategic acumen and my people leadership in companies driven by science.

Mes compétences :
Pack office
Diplomatie
Flexible et rapide capacité d'adaptation
Analytic
chef de produit
vétérinaire
industrie pharmaceutique
marketing
économie de la santé
santé
cardiologie
Biotechnologie
oncologie

Entreprises

  • Astrazeneca - AREA BUSINESS MANAGER RESPIRATORY – Primary Care – Canada

    Rueil-Malmaison 2018 - maintenant First Line Sales Manager in the Greater Toronto Area West
    Embracing with passion a new journey in sales management.
    I now support the growth of a talented team of 9 experienced sales representatives in the Greater Toronto Area (Toronto West, Mississauga, Oakville, Kitchener Waterloo, Brampton, Rexdale).
    Driving Symbicort and Aclidinium Franchise Sales

  • Astrazeneca - BRAND LEADER CARDIOLOGY – Specialty Care – Canada

    Rueil-Malmaison 2017 - 2018 • BRILINTA® brand leader relentlessly optimizing contribution to the organization by achieving biggest patient opportunities and enhancing cross functional spending

    • Full accountability to lead, inspire, drive and align the cross functional brand team

    • Shaped long-term forecasts and led BRILINTA 2018-2020 strategic plan achieving and maintaining global leadership in market share

    • Defined KOLs engagement strategy driving positive Canadian guidelines

    • Supporting multiple projects of the Access strategy

    Manager : Richard McLeod

  • AstraZeneca - MARKETING MANAGER CARDIOLOGY – Specialty Care – Canada

    Rueil-Malmaison 2015 - 2017 • Launched BRILINTA® (ticagrelor) new indication (strong KOLs consultancy and pre-launch activities, developed reps capabilities)

    • Led long term strategic and tactical plans resulting in global leadership in market share among top 10 AZ countries. Executive team “brand team of the year” award in 2015

    • Deployed a heightened KAM approach by changing the A&P investment model to prioritize regional growth opportunities. Awarded for generating an all-time high field-head office proximity

    • Coached 2 "ambassadors" spec reps to support strategic alignment and shift the business unit culture

    Managers : Rob Vitale | Darren Breckenridge

  • AstraZeneca - BRAND MANAGER CARDIOLOGY – Primary Care – France

    Rueil-Malmaison 2012 - 2015 • Built CRESTOR® (rosuvastatin) cross functional strategy and enhanced customer experience through a multi-canal approach, resulting in share gain despite payers incentives to Rx generic competitors. Brand leader and core member of the Global Brand Team

    • Pipeline commercial assessment for future BRILINTA® indications

    • Made AZ France a better place to work by renovating the ground floor of the headquarters

    • Coached 4 associate brand managers

    Manager: Matthieu Carer

  • Amgen - Jr BRAND MANAGER ONCOLOGY – Specialty Care – Belgium & Luxembourg

    PARIS 2011 - 2011 • Launched PROLIA® (denosumab) against cancer treatments induced bone loss in Belgium and Luxembourg (mainly campaign development). Developed NEULASTA® (pegfilgrastim) indication extension and VECTIBIX® (panitumumab) promotional campaigns

    • Re-launched the corporate website www.amgen.be

    Managers : Marie-Anne Lesure | Véronique Vanderroost | Ann Dhoore

  • Pfizer Animal Health - Jr BRAND MANAGER ONCOLOGY – Animal Health – Europe Africa Middle East

    Paris 2009 - 2009 • Pre-launched PALLADIA® (toceranib) at the European level (international KOLs management, built long term sales forecasts, campaign development)

    • Reorganized the combined Pfizer-Wyeth post-merger product portfolio (including business case re. antitrust legislation)

    • Analyzed synergies of several diagnostic companies before Synbiotics’ acquisition

    Manager: Olivier Franck

Formations

  • ESSEC Business School

    Cergy Pontoise 2009 - 2012 Master of Business Administration (MBA)


    • Marketing BtoB
    • New Product Development
    • Chaire of Health Economics. Major of promotion 2010
    • Chaire Sanofi-Aventis Therapeutic Innovation

  • Université Paris 5 René Descartes

    Paris 2008 - 2009 Master Legal Economics and Marketing of health industries With Honors

  • Ecole Nationale Vétérinaire D'Alfort

    Maisons Alfort 2005 - 2009 Doctor in Veterinary Medicine, Thesis: Launch Marketing Strategy of a new drug in oncology for dogs

Réseau

Annuaire des membres :